financetom
Business
financetom
/
Business
/
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
Oct 17, 2024 12:43 PM

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Uranium Energy Corp. ( UEC ) is going higher. “UEC's the real deal…We need more uranium. I think it's a great situation,” he added.

On Sept. 23, Uranium Energy ( UEC ) disclosed a deal to fully acquire Rio Tinto Plc ( RIO )‘s Wyoming assets for a purchase price of $175 million. As per the deal, the buyout includes the fully licensed Sweetwater Plant and a portfolio of uranium mining projects with around 175 million pounds of historic resources.

When asked about Novo Nordisk ( NVO ) , he said, “Doesn't hold a candle to Eli Lilly ( LLY ) .”

Sen. Elizabeth Warren (D-MA), last week, wrote a letter to the Federal Trade Commission's chair, Lina Khan, urging the department to investigate Novo Nordisk’s proposed $16.5 billion acquisition of contract development and manufacturing organization Catalent Inc ( CTLT ) thoroughly, amid growing concerns about potential antitrust violations. Critics argue that this merger could increase Novo Nordisk's ( NVO ) control over producing vital GLP-1 receptor agonists, drugs used to treat diabetes and obesity. This could potentially drive up prices and limit competition.

Cramer recommended staying away from Halliburton ( HAL ) .

On Monday, BofA Securities analyst Chase Mulvehill maintained Halliburton ( HAL ) with a Buy rating and lowered the price target from $40 to $38.

Price Action:

Novo Nordisk ( NVO ) shares fell 0.2% to settle at $119.78 on Monday.

Uranium Energy ( UEC ) shares gained 0.7% to close at $7.14.

Halliburton ( HAL ) shares fell 0.8% to close at $30.58 on Monday.

Read Next:

Wall Street’s Most Accurate Analysts Weigh In On 3 Tech And Telecom Stocks With Over 4% Dividend Yields

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Quest Diagnostics Margins a Blip as Fundamentals Stay Strong, Morgan Stanley Says
Quest Diagnostics Margins a Blip as Fundamentals Stay Strong, Morgan Stanley Says
Oct 22, 2025
11:59 AM EDT, 10/22/2025 (MT Newswires) -- Quest Diagnostics' ( DGX ) fundamentals remain strong despite a temporary margin blip that weighed on its stock, Morgan Stanley said in a note emailed Wednesday. The brokerage said margins were pressured by higher employee medical costs in Q3 and are expected to see another sequential decline in Q4 due to seasonal factors...
Omni Accelerates Growth With Acquisition of Explo
Omni Accelerates Growth With Acquisition of Explo
Oct 22, 2025
Omni’s projected to reach $30M ARR by year-end — representing 4x growth SAN FRANCISCO--(BUSINESS WIRE)-- Omni, the business intelligence and embedded analytics platform with a built-in semantic layer, announced the acquisition of Explo, a leading embedded analytics company. The acquisition comes during a period of rapid growth for Omni, with projected annual recurring revenue (ARR) reaching $30 million by the...
Smith & Nephew, UFC Extend Marketing Partnership
Smith & Nephew, UFC Extend Marketing Partnership
Oct 22, 2025
11:56 AM EDT, 10/22/2025 (MT Newswires) -- Smith & Nephew (SNN) and TKO Group's ( TKO ) UFC said Wednesday that they have signed a multi-year extension to their marketing partnership originally reached in 2024. Under the renewal, Smith & Nephew ( SNN ) will continue as UFC's Preferred Sports Medicine Technology Partner, they said. The parties did not disclose...
What's Going On With Amazon Stock Wednesday?
What's Going On With Amazon Stock Wednesday?
Oct 22, 2025
Shares of Amazon.com, Inc. ( AMZN ) are falling on Wednesday. The stock appears to be down following reports of a potential deal between Google and Anthropic. AMZN stock is trending lower. Get the scoop here. What To Know: Bloomberg reported that Google is in discussions regarding a cloud deal with Anthropic, an AI development company backed by both Google and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved